论文信息 - irRECIST for the Evaluation of Candidate Biomarkers of Response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma: Analysis of a Phase II Prospective Clinical Trial - 字舞流文

irRECIST for the Evaluation of Candidate Biomarkers of Response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma: Analysis of a Phase II Prospective Clinical Trial

P. Catalano | C. Horak | G. Freeman | Catherine J. Wu | S. Signoretti | R. Motzer | T. Choueiri | M. Atkins | F. Hodi | S. Shukla | A. Sharpe | Jean-Christophe Pignon | D. Braun | D. McDermott | M. Wind-Rotolo | O. Jegede | Y. Ishii | A. Flaifel | K. Mahoney | Jonian Grosha | Jesse S. Novak | G. Freeman